Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Steroid Refractory Graft Versus Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02027805
What this trial is testing

Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

Who this might be right for
Graft vs Host Disease
Xenikos 20
Early research (Phase 1)Study completedNCT01911039
What this trial is testing

Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD

Who this might be right for
Graft Versus Host DiseaseAllogeneic Hematopoietic Cell Transplant Recipient
Laura Johnston 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07602751
What this trial is testing

FMT for Pediatric SR-aGVHD

Who this might be right for
Acute Graft Versus Host Disease in Intestine
Bambino Gesù Hospital and Research Institute 20
Early research (Phase 1)Looking for participantsNCT06750133
What this trial is testing

Universal CNK-UT Therapy for Refractory aGVHD

Who this might be right for
Acute Graft-versus-Host Disease
First Affiliated Hospital of Zhejiang University 23
Not applicableStudy completedNCT04342442
What this trial is testing

Identification of Novel Targetable Kinases in SR-a GvHD

Who this might be right for
Graft Versus Host Disease
University of Freiburg 24
Testing effectiveness (Phase 2)Ended earlyNCT03422627
What this trial is testing

Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease

Who this might be right for
Chronic Graft Versus Host Disease cGVHD
Amgen 32
Testing effectiveness (Phase 2)Ended earlyNCT01903473
What this trial is testing

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Chronic Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseSteroid Refractory Graft-Versus-Host Disease
University of Liege 19
Not applicableApproved For MarketingNCT05722912
What this trial is testing

Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation
Testing effectiveness (Phase 2)UnknownNCT05368181
What this trial is testing

MAP-guided Preemptive Therapy of aGvHD

Who this might be right for
GVHD,AcuteStem Cell Transplant Complications
Sichuan University 56
Testing effectiveness (Phase 2)UnknownNCT04883918
What this trial is testing

ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

Who this might be right for
Acute-graft-versus-host Disease
ASC Therapeutics 60
Large-scale testing (Phase 3)UnknownNCT04289103
What this trial is testing

Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD

Who this might be right for
Steroid Refractory GVHD
ElsaLys Biotech 65
Large-scale testing (Phase 3)Study completedNCT00366145
What this trial is testing

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

Who this might be right for
Graft Versus Host Disease
Mesoblast, Inc. 260
Early research (Phase 1)Active Not RecruitingNCT01937468
What this trial is testing

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Chronic Graft Versus Host DiseaseChronic GVHDComplications of Organ Transplant Stem Cells
Dana-Farber Cancer Institute 25
Not applicableAvailableNCT05047328
What this trial is testing

Early Access Program With Inolimomab in Steroid-refractory Acute Graft Versus Host Disease

Who this might be right for
Steroid Resistant Acute Graft Versus Host Disease
ElsaLys Biotech
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576699
What this trial is testing

CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)

Who this might be right for
Steroid Refractory Graft Versus Host Disease
Cellenkos, Inc. 12
Testing effectiveness (Phase 2)UnknownNCT04189432
What this trial is testing

Efficacy and Safety of SCM-CGH in Patients With Steroid-Refractory or Dependent Chronic Graft-Versus-Host Disease

Who this might be right for
Chronic Graft-versus-host-disease
SCM Lifescience Co., LTD. 84
Early research (Phase 1)UnknownNCT06568328
What this trial is testing

Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

Who this might be right for
Graft vs Host Disease
Fujian Medical University 17
Early research (Phase 1)Study completedNCT00760981
What this trial is testing

A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host Disease
David Miklos 15
Testing effectiveness (Phase 2)Ended earlyNCT01485055
What this trial is testing

Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease

Who this might be right for
Graft Versus Host DiseaseSteroid Refractory GVHDAcute GVH Disease
Nationwide Children's Hospital 11
Early research (Phase 1)Ended earlyNCT04227938
What this trial is testing

ALPN-101 in Steroid-resistant or Steroid-refractory Acute GVHD

Who this might be right for
Graft Vs Host Disease
Alpine Immune Sciences, Inc. 1
Next Page